These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11873223)

  • 21. Alzheimer's drugs deliver fringe benefits. Cholinesterase inhibitors improve more than just memory.
    Auerbach SH
    Health News; 2003 Mar; 9(3):1-2. PubMed ID: 12703432
    [No Abstract]   [Full Text] [Related]  

  • 22. Drugs for Alzheimer's disease and related dementias.
    Gauthier S
    BMJ; 2005 Apr; 330(7496):857-8. PubMed ID: 15831849
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug treatments for Alzheimer's disease.
    Jackson GA
    Nurs Times; 2014 Feb 26-Mar 4; 110(9):24-6. PubMed ID: 24754108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current treatments for Alzheimer's disease: cholinesterase inhibitors.
    Doody RS
    J Clin Psychiatry; 2003; 64 Suppl 9():11-7. PubMed ID: 12934969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cholinesterase inhibitors in Alzheimer disease: preliminary recommendations for the practice].
    Schölzel-Dorenbos CJ; Jellesma-Eggenkamp MJ
    Ned Tijdschr Geneeskd; 1999 Jan; 143(2):122-3. PubMed ID: 10086120
    [No Abstract]   [Full Text] [Related]  

  • 26. [Drug therapy of Alzheimer's disease].
    Sulkava R
    Duodecim; 2000; 116(24):2867-73. PubMed ID: 12077892
    [No Abstract]   [Full Text] [Related]  

  • 27. Study notes huge costs associated with Alzheimer's disease.
    Levenson D
    Rep Med Guidel Outcomes Res; 2002 Feb; 13(4):7-9. PubMed ID: 12434776
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of drug treatments for Alzheimer's disease in France: a study on a national level based on the National Alzheimer's Data Bank (Banque Nationale Alzheimer).
    Tifratene K; Duff FL; Pradier C; Quetel J; Lafay P; Schück S; Benzenine E; Quantin C; Robert P
    Pharmacoepidemiol Drug Saf; 2012 Sep; 21(9):1005-12. PubMed ID: 22718684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The post-modern world of Alzheimer's disease trials: how much is an ADAS-cog point worth in central London?
    Schneider LS
    Int J Geriatr Psychiatry; 2006 Jan; 21(1):9-13. PubMed ID: 16353164
    [No Abstract]   [Full Text] [Related]  

  • 30. Cholinesterase inhibitors in late-stage Alzheimer's disease.
    Gauthier S
    Lancet Neurol; 2006 Jun; 5(6):468-9. PubMed ID: 16713915
    [No Abstract]   [Full Text] [Related]  

  • 31. Raw deal for dementia patients in the UK.
    Lancet Neurol; 2007 Oct; 6(10):839. PubMed ID: 17884665
    [No Abstract]   [Full Text] [Related]  

  • 32. Anticholinesterases in Alzheimer's disease: a modest effect on moderately severe disease.
    Prescrire Int; 2003 Dec; 12(68):230-1. PubMed ID: 14986699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Latest approaches in Alzheimer's care.
    Nadler-Moodie M; Wilson MF
    RN; 1998 Jul; 61(7):42-5; quiz 46. PubMed ID: 9687816
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of Alzheimer's disease.
    Mayeux R; Sano M
    N Engl J Med; 1999 Nov; 341(22):1670-9. PubMed ID: 10572156
    [No Abstract]   [Full Text] [Related]  

  • 35. Medical benefits.
    Iliffe S
    Br J Gen Pract; 2005 Nov; 55(520):886. PubMed ID: 16282015
    [No Abstract]   [Full Text] [Related]  

  • 36. [Questions and theses of pharmacological therapeutic options of Alzheimer's dementia with acetylcholinesterase inhibitors].
    van den Bussche H
    Z Gerontol Geriatr; 2005 Sep; 38 Suppl 1():I18-20. PubMed ID: 16189731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anticholinesterases in the treatment of Alzheimer's dementia--the first year's experience in Argyll & Clyde.
    Hughes A; Coulter F; Gillespie R; Livingston H; Phillips K; Quinn E; Rimmer E; Smith M; Walker A
    Health Bull (Edinb); 2000 Jan; 58(1):20-4. PubMed ID: 12813848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholinesterase inhibitors for Alzheimer's disease.
    Hitzeman N
    Am Fam Physician; 2006 Sep; 74(5):747-9. PubMed ID: 16970018
    [No Abstract]   [Full Text] [Related]  

  • 39. [Cholinesterase inhibitors in Alzheimer's disease].
    Ventura M; Sternon J
    J Pharm Belg; 2001; 56(3):62-8. PubMed ID: 11508260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacological therapy of Alzheimer's disease].
    Claus JJ; Hofman A; Jolles J
    Ned Tijdschr Geneeskd; 1992 Dec; 136(50):2463-6. PubMed ID: 1465168
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.